CORVUS PHARMACEUTICALS
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
CORVUS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.corvuspharma.com
Total Employee:
51+
Status:
Active
Contact:
+1 650 900 4520
Total Funding:
215.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Domain Not Resolving Apache
Similar Organizations
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company.
Actimed Therapeutics
Actimed Therapeutics is a clinical stage biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company.
Halia Therapeutics
Halia is a preclinical-stage biopharmaceutical company.
Innogen Pharmaceutical
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing and R&D company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Oxeia Biopharmaceuticals
Oxeia Biopharmaceuticals is a clinical stage biotech company.
SELLAS Life Sciences
SELLAS Life Sciences is a late-stage biopharmaceutical company.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
UroGen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.
Vyriad
Vyriad is a clinical stage biopharmaceutical company.
Zhaoke Ophthalmology Pharmaceutical
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Richard A Miller
Richard A Miller investment in Post-IPO Equity - Corvus Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Corvus Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Corvus Pharmaceuticals
Adams Street Partners
Adams Street Partners investment in Series B - Corvus Pharmaceuticals
BlackRock
BlackRock investment in Series B - Corvus Pharmaceuticals
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Corvus Pharmaceuticals
Novo Ventures
Novo Ventures investment in Series B - Corvus Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series B - Corvus Pharmaceuticals
OrbiMed
OrbiMed investment in Series A - Corvus Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-21 | Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research |
Official Site Inspections
http://www.corvuspharma.com Semrush global rank: 742.59 K Semrush visits lastest month: 54.57 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Corvus Pharmaceuticals"
Leadership | Corvus Pharmaceuticals
Mr. Morrison previously served on the boards of directors of the Life Sciences Foundation, a biotechnology nonprofit organization, the Bay Area Biosciences Association, a 501(c)(3) organization, and the Emerging Companies Section …See details»
About Us | Corvus Pharmaceuticals
Founded in 2014, Corvus has rapidly developed a deep pipeline of potentially breakthrough investigational medicines designed to be potent, selective and convenient to administer.See details»
Corvus Pharmaceuticals - Crunchbase Company Profile …
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.See details»
Corvus Pharmaceuticals - LinkedIn
Corvus Pharmaceuticals | 6,283 followers on LinkedIn. Collaborative agile teams with diverse perspectives, we are committed to learning, excellence and results. Join us! | Corvus is a unique ...See details»
Overview, News & Similar companies - ZoomInfo.com
May 10, 2024 Corvus Pharmaceuticals contact info: Phone number: (650) 900-4520 Website: www.corvuspharma.com What does Corvus Pharmaceuticals do? Corvus Pharmaceuticals is …See details»
Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business ...
BURLINGAME, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced the …See details»
Corvus Pharmaceuticals Announces Orphan Drug Designation …
Feb 8, 2024 Company on track to initiate soquelitinib Phase 3 registrational clinical trial in PTCLBURLINGAME, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, …See details»
Presentations | Corvus Pharmaceuticals
Nov 12, 2024 The Investor Relations website contains information about Corvus Pharmaceuticals's business for stockholders, potential investors, and financial analysts.See details»
Corvus Pharmaceuticals to Provide Business Update and Third …
Nov 5, 2024 Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com. INVESTOR CONTACT: Leiv …See details»
Corvus Pharmaceuticals Provides Business Update and Reports …
Aug 6, 2024 Conference call today at 4:30 p.m. ET / 1:30 p.m. PT. BURLINGAME, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) …See details»
Director/Senior Director, Analytical Development and Quality …
Able to build effective working relationships throughout the organization internally and externally to achieve goals. Flexibility and willingness to solve problems that fall outside of immediate …See details»
Corvus Pharmaceuticals to Provide Business Update and
Mar 21, 2023 For more information, visit www.corvuspharma.com. INVESTOR CONTACT: Leiv Lea Chief Financial Officer Corvus Pharmaceuticals, Inc. +1-650-900-4522 …See details»
Corvus Pharmaceuticals Announces Initiation of Placebo …
“The initiation of our Phase 1 atopic dermatitis trial is an important step towards unlocking the broad potential of ITK inhibition for immune diseases,” said Richard A. Miller, M.D., co ...See details»
Director of Human Resources | Corvus Pharmaceuticals
Lead the development and execution of HR policies and procedures, ensuring they are consistently applied across the organization. Qualifications. Bachelor’s degree in Human …See details»
Corvus Pharmaceuticals Presents New Interim Soquelitinib Data …
Dec 9, 2023 For more information, visit www.corvuspharma.com. About Soquelitinib Soquelitinib (formerly known as CPI-818) is an investigational small molecule drug given orally designed to …See details»
Corvus Pharmaceuticals Provides Business Update and Reports …
Sep 30, 2024 For more information, visit www.corvuspharma.com. About Soquelitinib Soquelitinib (formerly CPI-818) is an investigational small molecule drug given orally designed …See details»
Corvus Pharmaceuticals, Inc. (CRVS) - Yahoo Finance
Find the latest Corvus Pharmaceuticals, Inc. (CRVS) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Director/Senior Director, Chemical Development
Manages the activities of a chemical development group in the research, evaluation, and development and scale-up of one or more of the organization's products, projects, and …See details»
Corvus Pharmaceuticals Provides Business Update and Reports …
Sep 30, 2023 For more information, visit www.corvuspharma.com. About Soquelitinib Soquelitinib (CPI-818) is an investigational small molecule drug given orally designed to …See details»